PRESS RELEASE
11/08/2021
In compliance with the legal provisions in force on issuers and securities operations, the Board of Administrators of the Commercial Company Farmaceutica REMEDIA S.A. informs
In compliance with the legal provisions in force on issuers and securities operations, the Board of Administrators of the Commercial Company Farmaceutica REMEDIA S.A. informs
Farmaceutica REMEDIA ended 2020 with a net profit of 37.78 million RON, over 15 times larger than the one in 2019, of 2.441 million RON,
EGMS decision no. 75 / 14.10.2020, regarding the acquisition of own shares by Farmaceutica REMEDIA SA, through the public redemption offer, was published in the
The Board of Directors of Farmaceutica REMEDIA S.A. informs that the Report for the 3rd Quarter of 2020, consolidated – the full version – is
In compliance with the legal provisions in force on issuers and securities operations, the Board of Administrators of the Commercial Company Farmaceutica REMEDIA S.A. informs
The Board of Administrators of the Commercial Company Farmaceutica REMEDIA S.A., informs all those interested that it will organize, on November 13th, 2020, starting with
In compliance with the legal provisions in force on issuers and securities operations, the Board of Administrators of the Commercial Company Farmaceutica REMEDIA S.A. informs
The New Coronavirus 2019-nCoV Antigen Test, produced by Beijing Hotgen Biotech Co., Ltd, is a qualitative immunochromatographic test for the direct detection of SARS-CoV-2 proteins
REMEDIA is always with sports in Romania, promoting a healthy and active lifestyle.REMEDIA encourages physical activity and participation in competitions, so it supports the
The Board of Directors of Farmaceutica REMEDIA S.A. informs that the Report for the First Semester of 2020 – the full version – is available
